This study will test the effectiveness of naltrexone/bupropion medication as a maintenance therapy for the treatment of loss-of-control eating and weight loss following bariatric surgery. This is a controlled test of whether, amongst responders to acute treatments, naltrexone/bupropion medication results in superior maintenance and longer-term outcomes compared with placebo.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Loss-of-control eating Relapse
Timeframe: From baseline interview at study enrollment to after the 12-week treatment
Loss-of-control eating Relapse
Timeframe: From post-treatment to the 6-month follow-up
Loss-of-control eating Relapse
Timeframe: From post-treatment to the 12-month follow-up
Body Mass Index (BMI)
Timeframe: From baseline at study enrollment to after the 12-week treatment
Body Mass Index (BMI)
Timeframe: From post-treatment to the 6-month follow-up
Body Mass Index (BMI)
Timeframe: From post-treatment to the 12-month follow-up